Skip to main content

Table 2 Predictors of HZV dispensing rates for those aged 50 years or older*

From: Herpes zoster vaccine (HZV): utilization and coverage 2009 – 2013, Alberta, Canada

Variables

Reference group

OR1

95% CI2

Rural geography

Urban

0.68

0.53-0.87

Female sex

Male

1.44

1.35-1.53

Age group

50-54

  

55-59 years of age

 

2.14

1.96-2.33

60-64

 

4.71

4.33-5.13

65-69

 

6.64

6.10-7.24

70-74

 

6.50

5.95-7.10

75-79

 

5.86

5.35-6.40

80-84

 

4.13

3.76-4.54

85+

 

2.13

1.93-2.36

Year

2009

  

2010

 

11.69

9.08-15.07

2011

 

25.97

20.24-33.32

2012

 

105.41

82.41-134.83

2013

 

153.42

119.98-196.19

Income quintile

Q13

  

Q2

 

1.18

1.10-1.27

Q3

 

1.34

1.25-1.44

Q4

 

1.48

1.38-1.58

Q5

 

1.57

1.45-1.69

Two-way interaction terms

   

Geography*year

Urban*2009

  

Rural*2010

 

1.31

1.02-1.69

Rural*2011

 

1.20

0.94-1.54

Rural*2012

 

1.44

1.13-1.84

Rural*2013

 

1.57

1.22-2.00

Geography*income quintile

Urban*Q1

  

Rural*Q2

 

0.87

0.81-0.93

Rural*Q3

 

0.93

0.86-0.99

Rural*Q4

 

0.87

0.81-0.93

Rural*Q5

 

0.70

0.65-0.76

Sex*age group

Male*50-54

  

Female*55-59

 

0.96

0.88-1.04

Female*60-64

 

0.90

0.82-0.97

Female*65-69

 

0.87

0.80-0.94

Female*70-74

 

0.83

0.76-0.90

Female*75-79

 

0.81

0.75-0.89

Female*80-84

 

0.78

0.710.85

Female*85+

 

0.70

0.63-0.77

  1. *Adjusted estimates: adjusted for rural/urban geography, sex, 5-year age group, year, income quintile and 2-way interaction terms, ratio of pharmacies/total population.
  2. 1OR = odds ratio.
  3. 295% CI = 95% confidence interval.
  4. 3Q1 = income quintile 1 (lowest income quintile).